<html>
<head>PUBMED IDs for MYCBP</head>
<body bgcolor='#C5F0F2'><h1>MYCBP</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15979100/'>Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.</a> June 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18224412/'>Gene profiling of growth factor independence 1B gene (Gfi-1B) in leukemic cells.</a> January 29  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18633432/'>High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays.</a> July 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19758246/'>Signal transduction and gene transcription induced by TFF3 in oral keratinocytes.</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20562918/'>Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.</a> October 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/25330074/'>Global epigenetic regulation of microRNAs in multiple myeloma.</a> December 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25634536/'>High myopia-excavated optic disc anomaly associated with a frameshift mutation in the MYC-binding protein 2 gene (MYCBP2).</a> June 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25731699/'>MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.</a> June 24  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26244872/'>Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.</a> July 14  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26517351/'>Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.</a> September 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26886259/'>The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations.</a> July 21  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27620505/'>miR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells.</a> September 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28476684/'>miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway.</a> May 7  2017<br></body></html>
